86 related articles for article (PubMed ID: 33069693)
1. Disparities in the enrollment to systemic therapy and survival for patients with multiple myeloma.
Jayakrishnan TT; Bakalov V; Chahine Z; Lister J; Wegner RE; Sadashiv S
Hematol Oncol Stem Cell Ther; 2021 Sep; 14(3):218-230. PubMed ID: 33069693
[TBL] [Abstract][Full Text] [Related]
2. Socioeconomic status is independently associated with overall survival in patients with multiple myeloma.
Fiala MA; Finney JD; Liu J; Stockerl-Goldstein KE; Tomasson MH; Vij R; Wildes TM
Leuk Lymphoma; 2015; 56(9):2643-9. PubMed ID: 25651424
[TBL] [Abstract][Full Text] [Related]
3. Association of insurance disparities and survival in adults with multiple myeloma: A non-concurrent cohort study.
Makhani SS; Shively D; Castro G; Rodriguez de la Vega P; Barengo NC
Leuk Res; 2021 May; 104():106542. PubMed ID: 33721572
[TBL] [Abstract][Full Text] [Related]
4. Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.
Ailawadhi S; Frank RD; Sharma M; Menghani R; Temkit M; Paulus S; Khera N; Hashmi S; Advani P; Swaika A; Paulus A; Aslam N; Sher T; Roy V; Colon-Otero G; Chanan-Khan A
Cancer; 2018 Apr; 124(8):1710-1721. PubMed ID: 29360160
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Socioeconomic Risk Factors on the Survival Outcomes of Patients With Newly Diagnosed Multiple Myeloma: A Cross-analysis of a Population-based Registry and a Tertiary Care Center.
Evans LA; Go R; Warsame R; Nandakumar B; Buadi FK; Dispenzieri A; Dingli D; Lacy MQ; Hayman SR; Kapoor P; Leung N; Fonder A; Hobbs M; Hwa YL; Muchtar E; Kourelis TV; Russell S; Lust JA; Lin Y; Siddiqui M; Kyle RA; Gertz MA; Rajkumar SV; Kumar S; Gonsalves WI
Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):451-460.e2. PubMed ID: 33785296
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: a SEER-Medicare analysis.
Ailawadhi S; Parikh K; Abouzaid S; Zhou Z; Tang W; Clancy Z; Cheung C; Zhou ZY; Xie J
Blood Adv; 2019 Oct; 3(20):2986-2994. PubMed ID: 31648322
[TBL] [Abstract][Full Text] [Related]
7. Discrepancies in staging, treatment, and delays to treatment may explain disparities in bladder cancer outcomes: An update from the National Cancer Data Base (2004-2013).
Weiner AB; Keeter MK; Manjunath A; Meeks JJ
Urol Oncol; 2018 May; 36(5):237.e9-237.e17. PubMed ID: 29338913
[TBL] [Abstract][Full Text] [Related]
8. Differences in outcome for patients with cholangiocarcinoma: Racial/ethnic disparity or socioeconomic factors?
Lee RM; Liu Y; Gamboa AC; Staley CA; Kooby D; Russell MC; Cardona K; Maithel SK
Surg Oncol; 2020 Sep; 34():126-133. PubMed ID: 32891317
[TBL] [Abstract][Full Text] [Related]
9. Overall Survival in Patients With Multiple Myeloma in the U.S.: A Systematic Literature Review of Racial Disparities.
Mikhael J; Cichewicz A; Mearns ES; Girvan A; Pierre V; Rawashdh NA; Yellow-Duke A; Cornell RF; Nixon M
Clin Lymphoma Myeloma Leuk; 2024 Feb; 24(2):e1-e12. PubMed ID: 37923653
[TBL] [Abstract][Full Text] [Related]
10. Do Patients With Multiple Myeloma Enrolled in Clinical Trials Live Longer?
Aung TN; Bickell NA; Jagannath S; Kamath G; Meltzer J; Kunzel B; Egorova NN
Am J Clin Oncol; 2021 Dec; 44(12):603-612. PubMed ID: 34753885
[TBL] [Abstract][Full Text] [Related]
11. Racial and Socioeconomic Disparities in Mantle Cell Lymphoma.
Shah NN; Xi Y; Liu Y; Koff JL; Flowers CR; Behera M; Cohen JB
Clin Lymphoma Myeloma Leuk; 2019 Jun; 19(6):e312-e320. PubMed ID: 31029647
[TBL] [Abstract][Full Text] [Related]
12. Re: Disparities in Utilization of Autologous Hematopoietic Cell Transplantation for Treatment of Multiple Myeloma.
Fiala MA; Finney JD; Stockerl-Goldstein KE; Tomasson MH; DiPersio JF; Vij R; Wildes TM
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1153-4. PubMed ID: 25771403
[TBL] [Abstract][Full Text] [Related]
13. Survival disparities in non-small cell lung cancer by race, ethnicity, and socioeconomic status.
Tannenbaum SL; Koru-Sengul T; Zhao W; Miao F; Byrne MM
Cancer J; 2014; 20(4):237-45. PubMed ID: 25098282
[TBL] [Abstract][Full Text] [Related]
14. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma.
Mathur AK; Osborne NH; Lynch RJ; Ghaferi AA; Dimick JB; Sonnenday CJ
Arch Surg; 2010 Dec; 145(12):1158-63. PubMed ID: 21173289
[TBL] [Abstract][Full Text] [Related]
15. Autologous transplantation in multiple myeloma: a GITMO retrospective analysis on 290 patients. Gruppo Italiano Trapianti di Midollo Osseo.
Majolino I; Vignetti M; Meloni G; Vegna ML; Scimè R; Tringali S; Amaddii G; Coser P; Tribalto M; Raimondi R; Bergonzi C; Sajeva MR; Sica S; Ferrando F; Messina G; Mandelli F
Haematologica; 1999 Sep; 84(9):844-52. PubMed ID: 10477460
[TBL] [Abstract][Full Text] [Related]
16. Pattern of Care, Health Care Disparities, and Their Impact on Survival Outcomes in Stage IVB Cervical Cancer: A Nationwide Retrospective Cohort Study.
Jalloul RJ; Sharma S; Tung CS; O'Donnell B; Ludwig M
Int J Gynecol Cancer; 2018 Jun; 28(5):1003-1012. PubMed ID: 29757872
[TBL] [Abstract][Full Text] [Related]
17. Disparities in health care determine prognosis in newly diagnosed glioblastoma.
Chandra A; Rick JW; Dalle Ore C; Lau D; Nguyen AT; Carrera D; Bonte A; Molinaro AM; Theodosopoulos PV; McDermott MW; Berger MS; Aghi MK
Neurosurg Focus; 2018 Jun; 44(6):E16. PubMed ID: 29852776
[TBL] [Abstract][Full Text] [Related]
18. Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.
Hong S; Rybicki L; Abounader D; Bolwell BJ; Dean R; Gerds AT; Hamilton BK; Hill BT; Jagadeesh D; Kalaycio M; Liu HD; Pohlman B; Sobecks R; Majhail NS
Biol Blood Marrow Transplant; 2016 Jun; 22(6):1141-1144. PubMed ID: 26995694
[TBL] [Abstract][Full Text] [Related]
19. Insurance status and level of education predict disparities in receipt of treatment and survival for anal squamous cell carcinoma.
Patel KS; Alhatem A; Gadde U; Ahlawat S; Lambert C; Schwartz RA; Dalla Piazza M
Cancer Epidemiol; 2020 Aug; 67():101723. PubMed ID: 32408241
[TBL] [Abstract][Full Text] [Related]
20. Undertreatment of Older Patients With Newly Diagnosed Multiple Myeloma in the Era of Novel Therapies.
Fakhri B; Fiala MA; Tuchman SA; Wildes TM
Clin Lymphoma Myeloma Leuk; 2018 Mar; 18(3):219-224. PubMed ID: 29429818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
